CPC634

CriPec Docetaxel · Cristal Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CPC634, covering 2020-12-28 to 2020-12-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of CPC634 (CriPec® Docetaxel) in Platinum Resistant Ovarian Cancer [Phase 2]